DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20173281

Screening of alcohol de-addiction potential of zinc: a study on albino rats

Priya Gandigawad, Sharanabasayyaswamy B. Hiremath

Abstract


Background: With regard to tobacco and alcohol addiction, involvement of NMDA receptors and glutamate as neurotransmitter has been highlighted. Few indirect evidences support possible de-addiction potential of zinc being mediated through their interaction with nicotinic and NMDA receptors. The objectives of the present study were planned to analyze the alcohol de-addiction potential of oral zinc sulfate as a monotherapy and as a supplement to topiramate, in male wistar albino rats.

Methods: Male wistar albino rats were exposed to ‘two-bottle free choice’ model of voluntary ethanol consumption, wherein each animal had access to water and 10% v/v ethyl alcohol in two separate bottles. Thirty male rats divided into five groups, each containing six rats were treated as control group, receiving 1ml/kg/d distilled water orally; zinc sulfate group receiving 18mg/kg/d of elemental zinc orally; topiramate group receiving topiramate 5mg/kg/d, orally and Topiaramate plus Zinc sulfate group receiving both zinc sulfate (18mg/kg/d) and topiramate (5mg/kg/d) orally for two weeks.

Results: There were no significant differences with regard to all the three parameters in two-way ANOVA. However, there were significant differences with regard to amount of alcohol and water consumed but not API, in all the treatment groups in post-hoc test.

Conclusions: It is unclear on to the alcohol de-addiction potential of zinc as monotherapy and combination therapy with topiramate.


Keywords


Alcohol de-addiction, Topiramate, Zinc sulfate

Full Text:

PDF

References


Ali SF, Onaivi ES, Dodd PR, Cadet JL, Schenk S, Kuhar MJ, et al. Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists. Curr Neuropharmacol. 2011 Mar;9(1):2-7. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137181.

Pratima M, Manjunatha N, Subodh BN, Prabhat KC, Vivek B. Substance use and addiction research in India. Indian J Psychiatry. 2010;52:S189-99. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146212.

The addiction recovery guide. Your online guide to drug and alcohol ddiction recovery. 2017. Available at: http://www.addictionrecoveryguide.org/medication/alcoholism. Accessed on 19 May 2017.

Safai-Kutti S. Oral zinc supplementation in anorexia nervosa. Acta Psychiatr Scand. 1990;361:14-7. Available at: https://www.ncbi.nlm.nih.gov/pubmed/2291418.

Joshi M, Akhtar M, Najmi AK, Khuroo AH, Goswami D. Effect of zinc in animal models of anxiety, depression and psychosis. Hum Exp Toxicol. 2012;31:1237-43. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22549093.

Du J, Zhu M, Bao H, Li B, Dong Y, Xiao C, et al. The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors. Crit Rev Food Sci Nutr. 2014;3:0. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25365455.

Katalin T. Zinc in Neurotransmission. Annual Review of Nutrition. 2011;31:139-53. Available at: http://www.annualreviews.org/doi/abs/10.1146/annurev-nutr-072610-145218.

Nechifor M. Magnesium and Zinc Involvement in Tobacco Addiction. J Addict Res Ther. 2012;S2:005. Available at: https://www.omicsonline.org/magnesium-and-zinc-involvement-in-tobacco-addiction-2155-6105.S2-005.php?aid=6610.

Prior LP, Galduróz JC. Glutamatergic hyperfunctioning during alcohol withdrawal syndrome: Therapeutic perspective with zinc and magnesium. Medical Hypotheses. 2011;77:368-70. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21645973.

Arbaizar B, Dierssen-Sotos T, Gomez-Acebo I, Llorca J. Topiramate in the treatment of alcohol dependence: a meta-analysis. Actas Espanolas de Psiquiatria. 2010;38(1):8-12. Available at: https://www.ncbi.nlm.nih.gov/pubmed/20931405.

Morud J, Adermark L, Ericson M, Söderpalm B. Alterations in ethanol-induced accumbal transmission after acute and long-term zinc depletion. Addict Biol. 2015;20(1):170-81. Available at: https://www.ncbi.nlm.nih.gov/pubmed/24102995.

McCracken LM, Trudell JR, Goldstein BE, Harris RA, Mihic SJ. Zinc enhances ethanol modulation of the alpha1 glycine receptor. Neuropharmacology 2010;58(3):676-81. Available at: https://www.ncbi.nlm.nih.gov/pubmed/2864772.

McCracken LM, Trudell JR, McCracken ML, Harris RA. Zinc-dependent modulation of α2- and α3-glycine receptor subunits by ethanol. Alcohol Clin Exp Res. 2013;37(12):2002-10. Available at: https://www.ncbi.nlm.nih.gov/pubmed/4452379.

McCracken LM, Blednov YA, Trudell JR, Benavidez JM, Betz H, Harris RA. Mutation of a zinc-binding residue in the glycine receptor α1 subunit changes ethanol sensitivity in vitro and alcohol consumption in vivo. J Pharmacol Exp Ther. 2013;344(2):489-500. Available at: https://www.ncbi.nlm.nih.gov/pubmed/3558822.

Kirson D, Cornelison GL, Philpo AE, Todorovic J, Mihic SJ. Physiological concentrations of zinc reduce taurine-activated GlyR responses to drugs of abuse. Neuropharmacology. 2013;75:286-94. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23973295.

Medscape news and perspectives. Topiramate in the Treatment of Alcohol Use Disorders 2015. Available at: http://www.medscape.com/viewarticle/851686. Accessed 19 May 2017.